Le chemin vers la maternité est profondément personnel, et pour les femmes confrontées à des défis tels que l’infertilité ou les risques liés à une grossesse tardive, la gestation pour autrui (GPA) offre une alternative. Le désir d’élever un enfant ne s’estompe pas avec l’âge ou les circonstances. Au contraire, il ne fait que s’intensifier avec le temps, et la GPA est l’une des voies permettant de réaliser ce rêve.
Researchers from the UK and the Netherlands have identified a 'genetic signature' in the womb that could help explain repeated IVF failure in some women.
"Many women undergo a number of IVF cycles without success despite having good quality embryos and, up to now, it has been unclear whether or not the lining of the womb may be the cause of that," said study co-lead Professor Nick Macklon, medical director of Complete Fertility Centre Southampton.
Scientists have discovered that the use of painkillers during pregnancy in rats may reduce the fertility of their offspring.
The study shows that rats who were put on a course of paracetamol or prescription-only drug indomethacin gave birth to female offspring with fewer eggs, smaller ovaries, and who had smaller litters themselves.
The effects of the painkillers were even observed in the subsequent generation – the granddaughters of the initial test subjects were found to have smaller ovaries and altered reproductive function.
A new IVF technique has been developed which allows fertilisation to occur in the womb rather than in the laboratory.
The technique involves putting the sperm and egg together in a small silicone capsule, which is then placed into the womb. The device, called AneVivo, is one centimetre long and one millimetre wide and contains hundreds of tiny holes that allow the fluids from the womb to surround the egg and sperm as would occur during a natural conception. After 24 hours, the capsule is removed to allow doctors to select the healthiest embryo, which is then re-implanted back into the womb.
